[1]Makarova MN, Pozharitskaya ON, Shikov AN, et al. Effect of lipidbased suspension of Epimedium koreanum Nakai extract on sexual behavior in rats[J]. J Ethnopharmacol, 2007, 114(3): 412416.
[2]李娌, 王学美. 淫羊藿苷药理作用研究进展[J]. 中国中药杂志, 2008, 33(23): 27272732.
[3]刘雪琴, 何燕. 淫羊藿苷药理作用研究进展[J]. 中国中医药科技, 2012, 19(4): 379380,382.
[4]贾亮亮, 袁丁, 王洪武, 等. 淫羊藿苷药理作用的研究进展[J]. 现代生物医学进展, 2010, 10(20): 39763979.
[5]Luo Y, Nie J, Gong QH, et al. Protective effects of icariin against learning and memory deficits induced by aluminium in rats[J]. Clin Exp Pharmacol Physiol, 2007, 34(8): 792795.
[6]聂晶, 罗勇, 黄燮南, 等. 淫羊藿苷对淀粉样β蛋白片段2535所致大鼠学习记忆障碍的改善作用[J]. 中国药理学与毒理学杂志, 2008, 22(1): 3137.
[7]He XL, Zhou WQ, Bi MG, et al. Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescenceaccelerated mouse prone 8 (SAMP8) mice[J]. Brain Res 2010, (1334): 7383.
[8]Guo J, Li F, Wu Q, et al. Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats[J]. Phytomedicine, 2010, 17(12): 950955.
[9]Zeng KW, Fu H, Liu GX, et al. Icariin attenuates lipopolysaccharideinduced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NFkappaB and JNK/p38 MAPK pathways[J]. Int Immunopharmacol, 2010, 10(6): 668678.
[10]甄瑾, 李润今, 王梅玲. 淫羊藿苷对阿尔茨海默病模型大鼠记忆能力及其海马内GFAP、TNFα、IL6表达的影响[J]. 中西医结合心脑血管病杂志, 2013, 11(2): 192194.
[11]Li L, Zhou QX, Shi JS. Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion[J]. Chin Med J (Engl), 2005, 118(19): 16371643.
[12]王晓云, 王翀, 黄嵘. 淫羊藿苷对神经细胞缺血再灌注损害的保护作用及其机制研究[J]. 临床神经病学杂志, 2012, 25(5): 365367.
[13]Zhu HR, Wang ZY, Zhu XL, et al. Icariin protects against brain injury by enhancing SIRT1dependent PGC1alpha expression in experimental stroke[J]. Neuropharmacology ,2010, 59(12): 7076.
[14]Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC1alpha and SIRT1[J]. Nature, 2005, 434(7029): 113118.
[15]Wang L, Zhang L, Chen ZB, et al. Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1[J]. Eur J Pharmacol, 2009, 609(13): 4044.
[16]高琳娜, 贺晓丽, 唐千淇, 等. 淫羊藿苷对快速老化小鼠SAMP10脑组织单胺类及氨基酸类神经递质的影响[J]. 中国临床药理学与治疗学, 2012, 17(10): 10811086.
[17]Binder DK, Scharfman HE. Brainderived neurotrophic factor[J]. Growth factors (Chur, Switzerland), 2004, 22(3): 123131.
[18]龚其海, 李菲, 黄彬, 等. 脑源性神经营养因子:治疗阿尔采末病的新策略[J]. 中国新药与临床杂志, 2011, (4): 245250.
[19]Ando S, Kobayashi S, Waki H, et al. Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine[J]. J Neurosci Res, 2002, 70(3): 519527.
[20]Li F, Gong QH, Wu Q, et al. Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by dgalactose in rats[J]. Pharmacol Biochem Behav, 2010, 96(3): 301305.
[21]Liu B, Zhang H, Xu C, et al. Neuroprotective effects of icariin on corticosteroneinduced apoptosis in primary cultured rat hippocampal neurons[J]. Brain Res, 2011, 1375: 5967.
[22]Cerpa W, Toledo EM, VarelaNallar L, et al. The role of Wnt signaling in neuroprotection[J]. Drug News Perspect, 2009, 22(10): 579591.
[23]曾克武, 王学美, 富宏, 等. 淫羊藿苷通过Wnt/βcatenin信号通路抑制淀粉样蛋白Aβ_(2535)所诱导的神经毒性[J]. 中国药学杂志, 2011, 46(22): 17191722.
[24]Zeng KW, Ko H, Yang HO, et al. Icariin attenuates betaamyloidinduced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells[J]. Neuropharmacology, 2010, 59(6): 542550.
[25]Price SA, Held B, Pearson HA. Amyloid beta protein increases Ca2+ currents in rat cerebellar granule neurones[J]. Neuroreport, 1998, 9(3): 539545.
[26]Li L, Tsai HJ, Li L, et al. Icariin inhibits the increased inward calcium currents induced by amyloidbeta(2535) peptide in CA1 pyramidal neurons of neonatal rat hippocampal slice[J]. Am J Chin Med, 2010, 38(1): 113125.
[27]Zhang L, Huang S, Chen Y, et al. Icariin inhibits hydrogen peroxidemediated cytotoxicity by upregulating sirtuin type 1dependent catalase and peroxiredoxin[J]. Basic Clin Pharmacol Toxicol, 2010, 107(5): 899905.
[28]Chen SR, Xu XZ, Wang YH, et al. Icariin derivative inhibits inflammation through suppression of p38 mitogenactivated protein kinase and nuclear factorkappa B pathways[J]. Biol Pharm Bull, 2010, 33(8): 13071313.